EverHint Signal — EMA10 × EMA30 Crossover — November 25, 2025
What This Signal Is (Quick)
The EMA10 × EMA30 Crossover captures short-term momentum shifts:
- Buy (EMA10 > EMA30):
Short-term strength overtakes medium-term trend — potential early upside inflection. - Sell (EMA10 < EMA30):
Short-term weakness undercuts the 30-day trend — early deterioration or exit cue.
This strategy reacts fast, picks up market turns early, and intentionally takes more signals than slower SMA systems. That speed makes it powerful but also prone to whipsaws in volatile markets — which matters today, given the elevated VIX.
This is an experimental scanner, intended for research and swing-trade exploration, not trade recommendations.
📈 All BUY Signals — Ranked by RSI(14)
(RSI ascending — lower RSI = earlier stage in the momentum turn)
Note: EMA10×EMA30 Buy signals were limited today. All are shown below.
| Rank | Ticker | Company | Sector | Last ($) | RSI(14) | Market Cap | Insider Net | Days → Earnings | Liquidity (20d $) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | 55.50 | 58.8 | 10.7B | $0 | 64 (amc) | 177.6M |
| 2 | ARE | Alexandria Real Estate Equities | Real Estate | 115.24 | 58.8 | 19.8B | $0 | 76 (amc) | 144.0M |
| 3 | OTIS | Otis Worldwide Corp. | Industrials | 95.80 | 65.0 | 38.9B | $0 | 81 (bmo) | 227.4M |
| 4 | EXAS | Exact Sciences Corp. | Healthcare | 100.90 | 67.8 | 19.1B | –$1.30M | 86 (amc) | 700.9M |
Buy-Side Read
- RSI cluster (58–68) → These are not early reversals; they are momentum continuation Buy signals.
- BMRN & ARE (RSI 58.8) → earliest potential entries among Buy signals.
- EXAS (RSI 67.8) → high momentum continuation but with net insider selling (–1.3M), a key caution flag.
- OTIS → clean industrial trend; trending steadily with no insider contradictions.
These Buys reflect strength in Healthcare, Industrials, and Real Estate, consistent with defensive + growth blend performance noted in late November 2025.
📉 All SELL Signals — Ranked by RSI(14)
(RSI ascending — lowest RSI = most oversold under a fresh Sell crossover)
Sell signals were dominant today. All are included, sorted by RSI(14).
| Rank | Ticker | Company | Sector | Last ($) | RSI(14) | Market Cap | Insider Net | Days → Earnings | Liquidity (20d $) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SUPN | Supernus Pharmaceuticals | Healthcare | 45.15 | 16.2 | 2.5B | –$78.7K | N/A | 54.2M |
| 2 | PANW | Palo Alto Networks | Technology | 183.89 | 17.7 | 123B | –$154K | 80 (amc) | 1.2B |
| 3 | PDD | PDD Holdings | Consumer Cyclical | 113.49 | 18.2 | 158.8B | $0 | N/A | 967.4M |
| 4 | BHVN | Biohaven | Healthcare | 9.68 | 19.9 | 1.0B | +$30.6M | N/A | 38.7M |
| 5 | ASTS | AST SpaceMobile | Technology | 55.00 | 28.7 | 16.4B | –$1.0M | N/A | 627.1M |
| 6 | FLR | Fluor Corporation | Industrials | 41.22 | 31.8 | 6.6B | $0 | 85 (bmo) | 156.3M |
| 7 | CSX | CSX Corporation | Industrials | 34.39 | 32.3 | 64.0B | +$15.8K | 59 (amc) | 424.8M |
| 8 | CNI | Canadian National Railway | Industrials | 90.91 | 33.8 | 57.0B | $0 | 66 (amc) | 127.1M |
| 9 | CAMT | Camtek Ltd. | Technology | 101.15 | 34.6 | 4.6B | $0 | 79 (bmo) | 56.1M |
| 10 | BILI | Bilibili Inc. | Comm. Services | 26.38 | 34.9 | 11.0B | $0 | 87 (bmo) | 72.7M |
Sell-Side Read
- RSI cluster (16–35) → deep oversold readings under Sell crossovers.
- SUPN, PANW, PDD, BHVN → exceptionally low RSI (<20), marking heavy pressure or capitulation-like behavior.
- BHVN anomaly → strong insider buying (+30.6M) despite low RSI — a major divergence worth monitoring.
- Industrials group (FLR, CSX, CNI) → mid-RSI Sell signals, often marking multi-week downtrends rather than breakdowns.
- Tech laggards (ASTS, CAMT) → oversold with fundamental uncertainty or high-beta volatility.
Sell-side dominance in an elevated VIX environment often signals persistent sector rotation or macro stress.
Recent Headlines Highlights
(Summarized, rewritten per instructions)
- PANW — Analysts debate valuation reset vs. long-term cybersecurity strength; still widely rated “Buy,” but with cautious near-term tone.
- PDD — Heavy investor attention; debates focus on growth sustainability under competitive pressure.
- BHVN — Multiple reports highlight significant insider accumulation, suggesting internal confidence despite price weakness.
- ASTS — Satellite-connectivity narrative resurfacing; analysts compare long-term potential vs. execution risk.
- BILI — Brokers maintain “Moderate Buy”; commentary centers on monetization and user engagement trends.
Market Backdrop — November 25, 2025
From the markets snapshot:
- S&P 500 (SPX): slightly lower
- Nasdaq: modest red
- Dow: flat
- Russell 2000: underperformed
- VIX: elevated (>20), signaling continued stress
- 10-Year Treasury Yield (~4.05%): steady
- Crypto: BTC and ETH softer
This environment aligns with:
- Buy signals showing trend follow-through, but not early reversals
- Sell signals dominating the oversold cluster, suggesting persistent pressure across several sectors
When VIX stays above 20, EMA10×EMA30 whipsaws increase — which means entries must be treated as short-horizon, small-size swings, not broad allocation shifts.
Vlad’s Take (EverHint)
- Buy signals (RSI ~58–68) are trend-following confirmations, not early reversals. These are strong names behaving the “right” way in a mixed tape.
- Sell signals (RSI ~16–35) are where real stress is happening — they represent the most fragile spots in the market.
- BHVN stands out: insider accumulation despite a Sell signal and sub-20 RSI — these divergences often become future watchlist names.
- Elevated VIX means the tape is still unstable.
- Treat Buy signals as shorter-term continuation trades.
- Treat Sell signals as risk-off or future contrarian watchlist entries, depending on your style.
EMA10×EMA30 often captures the very first sign of a turn — but that makes discipline and stops essential when volatility is this high.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/